Foresight Biosciences moving research discoveries to market

February 24, 2015

HUNTSVILLE, Ala. — Foresight Biosciences, an associate company at the HudsonAlpha Institute for Biotechnology, announces its enzymes and assay kits are now available to the glycobiology and pharmaceutical research markets. “Much of the available technology has not been optimized for studying the biology of sugars and sugar polymers,” said Randall […]

Read Story

New ALS Gene and Signaling Pathways Identified

February 19, 2015

Findings point to potential therapeutic targets  HUNTSVILLE, Ala., CAMBRIDGE, Mass., and NEW YORK — February 19, 2015 — Using advanced DNA sequencing methods, an international consortium that includes scientists and clinicians from HudsonAlpha Institute for Biotechnology, Columbia University Medical Center (CUMC) and Biogen Idec (NASDAQ: BIIB) has identified a new gene […]

Read Story

Faculty Investigator develops method to capture large, contiguous blocks of genome for sequencing

February 2, 2015

Faculty Investigator Devin Absher, Ph.D., took a new procedure, which he developed, that can capture large, contiguous blocks of the genome for sequencing applications, and turned it into one of HudsonAlpha’s newest associate companies. The development of the procedure was the subject of the paper “Targeted Sequencing of Large Genomic […]

Read Story

Conversant Bio Accepting Application for Biobank Financial Sustainability Grant

January 15, 2015

HudsonAlpha Associate Company Sponsors $50,000 Grant Opportunity Huntsville, Ala. — Conversant Bio, a global leader in supplying the highest-quality human tissue and viable cell samples to the top U.S. Bio Pharmas and Biotechs to advance research, today announced it is sponsoring a grant to advance understanding of financial sustainability in the […]

Read Story

iCubate® conducting clinical studies on test to detect deadly bacteria

January 14, 2015

Huntsville, Ala. — iCubate® Inc. announced today that it has begun clinical studies for the company’s first product for clinical diagnostic use. iCubate® will seek FDA clearance as an in-vitro diagnostic test to be used for the identification and detection of Gram-positive bacteria, which are the most common cause of […]

Read Story

HudsonAlpha scientists discover new biomarkers for kidney cancer

January 5, 2015

Novel method may lead to earlier detection of renal cell carcinoma Huntsville, Ala. — Researchers at the HudsonAlpha Institute for Biotechnology have discovered new “biomarkers” that are very strong predictors of renal cell carcinoma, the most common type of kidney cancer in adults.  These markers are a set of about […]

Read Story

Dr. Richard Myers Reflects on Anniversary of Alta Summit

December 18, 2014

Thirty years ago, in December, 1984, Richard Myers was battling a nasty case of altitude sickness. At the time a young postdoctoral scholar, Myers, joined 18 other researchers at a gathering 8,500 feet above sea level, at the Alta ski resort near Salt Lake City, Utah. The weather outside was stormy, […]

Read Story

HudsonAlpha associate company receives second research contract from FDA

December 18, 2014

Innovative research will support tools for the detection of potential biodefense agents Huntsville, Ala. — Diatherix Laboratories, Inc., has been awarded a federal contract to continue its groundbreaking work in the development of research methodologies designed to support the development of diagnostic tools to detect certain low prevalence pathogens. The […]

Read Story

HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system

December 12, 2014

Technology will quadruple HudsonAlpha’s DNA sequencing capacity to help genomic information reach thousands of patients Huntsville, Ala. — December 12, 2014 — HudsonAlpha Institute for Biotechnology today announced it has purchased the HiSeq X Ten sequencing system manufactured by Illumina, Inc. (NASDQ: ILMN). The technology will enable HudsonAlpha to produce and analyze […]

Read Story

HudsonAlpha announces $500,000 raised for Breakthrough Breast Cancer Fund

November 17, 2014

Proceeds will help hire a breast and ovarian cancer researcher Huntsville, Ala. — The HudsonAlpha Breakthrough Breast/Ovarian Cancer Fund raised more than $300,000 and will receive a $250,000 match from the Lonnie McMillian Inspiring Excellence endowment fund, leaders announced Monday. The announcement was made at the Institute’s annual Tie the […]

Read Story